Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005

Poulos, L; Waters, Anne-Marie; Correll, Patricia; Loblay, Robert H.; Marks, Guy B.

doi:10.1016/j.jaci.2007.07.040

Cited by 323 publications

(272 citation statements)

References 28 publications

Supporting

Mentioning

242

Contrasting

Unclassified

Order By: Relevance

“…The hospitalization rate for anaphylaxis increased more than fourfold during the studied period (from 1/100 000 to 4.7/100 000). In a similar nation-wide analysis (Australia National Hospital Morbidity Database) (17), for the period 1993-2005, there was a continuous increase in the rate of hospital admissions for anaphylaxis of 8.8% per year ( Fig. 1), with a particularly steep increase in food-related anaphylaxis among children aged <5 years.…”

Section: Prevalencementioning

confidence: 85%

Anaphylaxis treatment: current barriers to adrenaline auto-injector use

Song

Worm

Lieberman

2014

Allergy

View full text Add to dashboard Cite

To cite this article: Song TT, Worm M, Lieberman P. Anaphylaxis treatment: current barriers to adrenaline auto-injector use. AbstractAnaphylaxis is a life-threatening condition that is increasing in prevalence in the developed world. There is universal expert agreement that rapid intramuscular injection of adrenaline is life-saving and constitutes the first-line treatment of anaphylaxis. The unpredictable nature of anaphylaxis and its rapid progression makes necessary the availability of a portable emergency treatment suitable for self-administration. Thus, anaphylaxis treatment guidelines recommend that at-risk patients are provided with adrenaline auto-injectors (AAIs). Despite these clear recommendations, current emergency treatment of anaphylaxis continues to be inadequate in many cases. The aim of this review is to highlight the barriers that exist to the use and availability of AAIs and that prevent proper management of anaphylaxis. In addition, we review the characteristics of all AAIs that are presently available in Europe and the USA and discuss the need for regulatory requirements to establish the performance characteristics of these devices.

show abstract

Section: Prevalencementioning

confidence: 85%

Anaphylaxis treatment: current barriers to adrenaline auto-injector use

Song

Worm

Lieberman

2014

Allergy

View full text Add to dashboard Cite

show abstract

“…The incidence of other allergic conditions such as asthma has been found to be increasing over time. Whether this is the case also with anaphylaxis is not known, but studies in UK and Australia show there has been an increase in hospitalization for anaphylaxis (29,30). A pan-European register could also provide information on such trends.…”

Section: Discussionmentioning

confidence: 99%

Towards a European registry of severe allergic reactions: current status of national registries and future needs

Worm

Timmermans²,

Moneret-Vautrin

et al. 2010

Allergy

View full text Add to dashboard Cite

Allergies are among the most common diseases and food allergy as a common cause of severe allergic reactions is estimated to affect between 2% and 4% of the population of industrialized countries, with a prevalence of up to 8% in children. The burden on those directly affected, as well as on their families, is being increasingly recognized (1). Ongoing research is likely to provide accurate and reliable information on the size of the population at risk, as well as the importance of different allergenic foods. Research is also generating information about the distribution of minimum eliciting doses within the allergic population for the more common allergenic foods.The present lack of data impairs estimation of the public health impact of allergic reactions in general and in particular reactions to foods. The effectiveness of allergen control measures and educational efforts for prevention are difficult to evaluate and prioritise. Absence of such information also affects the clinical management of allergic reactions, as experience with regard to treatment, circumstances and etiological agents is not collected systematically and effectively. The present article examines the systems that have been put in place in several European countries for recording severe allergic reactions. It then considers the type of information that such registries should hold to meet the needs of different stakeholders (clinical, public health, regulatory, industrial) and outlines a proposal for a pan-European registry of severe allergic reactions. Severe allergic reactions -a public health problem in EuropeAnaphylaxis is the most severe manifestation of an allergic reaction (2). It may occur following exposure to allergens from a variety of sources including foods, insect venom, drugs and others. An international symposium acknowledged AbstractThe incidence of severe allergic reactions is largely unknown and information about triggering allergens, aggravating factors, demography of patients and medical care is lacking. A European wide registry could provide a powerful tool to improve the management of severe allergic reactions from both a medical and a public health perspective. Analysis of existing registries regarding the type and quality of data being collected was used to develop a plan for a pan-European registry, including the type of system to be used and the range of data to be entered. Surveillance will provide evidence for the efficacy of risk management measures and may identify the emergence of new allergenic foods, and aid monitoring of novel foods, ingredients and technologies. Patients need a clear indication of factors that may increase their risk of having an adverse reaction, which such a registry can help compile. Based on the collected data, food businesses will be able to develop educational programmes for allergen risk assessment and allergen risk communication. Finally, and most importantly preventive measures can be developed and government agencies receive population based data which may be relevant for legisla...

show abstract

“…There has been a significant increase in the incidence of food allergies including a rise of Emergency Department visits for food allergic reactions. [29][30], moreover peanut allergy prevalence in children in US and England doubled in the last few years in identical telephone surveys. [31][32].…”

Section: Epidemiologymentioning

confidence: 98%

The Progress of Food Allergy Concept, Classifications and Diagnosis

Kamal-Alahmad¹

2016

IJNFS

View full text Add to dashboard Cite

Food allergies, defined as an immune response to food proteins, affect as many as 8% of young children and 5% of adults in most countries, and their prevalence appears to be rising like all allergic diseases, In addition to well-recognized urticaria and anaphylaxis triggered by IgE antibody-mediated immune responses. Food allergy is a rapidly growing public health concern because of its increasing prevalence and life-threatening potential. Food allergic reaction can be further subdivided into IgE mediated and non IgE mediated. The diagnosis of food allergy is made from the history, supported by investigations and by responses to avoidance of specific food triggers. So in this work we want to introduce some concepts in food allergy such as classification of allergic and diagnosis of food triggers and finally how to manage this problem and minimize the prevalence of food allergy.

show abstract

Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005

Cited by 323 publications

References 28 publications

Anaphylaxis treatment: current barriers to adrenaline auto-injector use

Anaphylaxis treatment: current barriers to adrenaline auto-injector use

Towards a European registry of severe allergic reactions: current status of national registries and future needs

The Progress of Food Allergy Concept, Classifications and Diagnosis

Contact Info

Product

Resources

About